Clinical Trial Update: Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating reduced immunosuppressive therapy with or without donor white blood cells in patients with post-transplant lymphoproliferative disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-transplant Lymphoproliferative Disorder

Snippet

Sponsor: University of Edinburgh | Conditions: Lymphoproliferative Disorder | Phase 3 | Status: COMPLETED